Cervical mucinous adenocarcinoma

Summary

Cervical mucinous adenocarcinoma (MONDO:0002742) is a disease (an umbrella term covering 6 Mondo subtypes). A subtype of mucinous adenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 6 Mondo subtypes

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	cervical mucinous adenocarcinoma
Mondo ID	MONDO:0002742
DOID	DOID:3701
NCIT	C36095
UMLS	C1332919
MedGen	232048
GARD	0023229
Anatomy (UBERON)	UBERON:0000002
Is cancer (heuristic)	no

Also known as: cervical mucinous adenocarcinoma · uterine cervix mucinous adenocarcinoma

Data availability: 1 cell line.

Disease family

This is a subtype of mucinous adenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › mucinous adenocarcinoma › cervical mucinous adenocarcinoma

Related subtypes (16): breast mucinous carcinoma, extrahepatic bile duct mucinous adenocarcinoma, fallopian tube mucinous adenocarcinoma, endometrial mucinous adenocarcinoma, rectum mucinous adenocarcinoma, mucoepidermoid carcinoma, gallbladder mucinous adenocarcinoma, colloid carcinoma of the pancreas, colon mucinous adenocarcinoma, ovarian mucinous adenocarcinoma, mucinous cystadenocarcinoma, acinar prostate mucinous adenocarcinoma, mucinous gastric adenocarcinoma, lung colloid adenocarcinoma, mucinous pancreas adenocarcinoma, salivary gland mucinous adenocarcinoma

Subtypes (6): uterine ligament mucinous adenocarcinoma, signet ring cell variant cervical mucinous adenocarcinoma, intestinal variant cervical mucinous adenocarcinoma, endocervical type cervical mucinous adenocarcinoma, cervical mucinous adenocarcinoma, minimal deviation variant, cervical villoglandular adenocarcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.